Clinical Trial Update: Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating rivaroxaban after transradial access to prevent radial artery occlusion, currently recruiting. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radial Artery Occlusion

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Radial Artery Occlusion | Phase 3 | Status: RECRUITING